QA: Sonoma Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367083_2023_Sonoma_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001367083, Sonoma Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 16,430,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 320,000
3 remainder_Assets 2,095,000
4 LiabilitiesCurrent 5,819,000
5 LiabilitiesNoncurrent 309,000
6 remainder_Liabilities 4,020,000
7 CostOfGoodsAndServicesSold 8,635,000
8 SellingGeneralAndAdministrativeExpense 9,755,000
9 ResearchAndDevelopmentExpense 125,000
10 remainder_Expenses -332,000
11 remainder_Revenues 12,628,000
12 remainder_NetIncome 469,000
13 remainder_ComprehensiveNetIncome 267,000
  yvar yval
0 Assets 18,845,000
1 Liabilities 10,148,000
2 Expenses 18,183,000
3 Revenues 12,628,000
4 StockholdersEquity 8,697,000
5 NetIncome -5,086,000
6 ComprehensiveNetIncome -4,952,500
7 BaseVar 30,270,000
8 EconomicCapitalRatio 0.690

Edgar->Model Mapping

Feature Distribution

Change over Time